Quality-of-life results of double-blind, placebo-controlled trial of mesalamine in patients with Crohn's disease.
Quality-of-life results of double-blind, placebo-controlled trial of mesalamine in patients with Crohn's disease. Dig Dis Sci. 1995 May; 40(5):931-5.